The use of different antibodies, staining standards, tumor material, scores for positivity, and the inclusion of variously selected groups of breast cancer patients might be the reason why the frequency of positive p53 staining ranges from 20 to 60% in the literature [29–31]. Here, TP53 is linked to neoplasm.